Lilly Falls on Oral Obesity Pill as FDA Decision Looms
Eli Lilly stock fell about 5% as investors awaited the FDA's April decision on orforglipron. Novo Nordisk's intensifi...
Looking for short term gigs? Discover where to find quick cash options that fit your schedule.
25,797 articlesEli Lilly stock fell about 5% as investors awaited the FDA's April decision on orforglipron. Novo Nordisk's intensifi...
March brings renewed focus on artificial intelligence (ai) stocks as growth drivers focus on real products and predic...
Eli Lilly has faced a pullback that can create long-term buying opportunities. This guide explores using a budget-fri...
Friday's session put cybersecurity stocks in retreat as investors priced in AI-driven commoditization risks. Palo Alt...
Tech giants drive a broad market surge as AI earnings power gains push the Nasdaq toward a nasdaq defy gravity record...
Amphastar delivered a careful Q1 2026 showing steady revenue momentum and margin discipline. This guide breaks down t...
Cardano has weathered wild crypto cycles before. This guide lays out credible scenarios for 2030, explains what could...
SolarEdge and Enphase surged as residential solar demand improved, while Canadian Solar slid, underscoring a sharp sp...
Hedge fund founder Jeffrey Gundlach warns the Fed won’t cut rates at the upcoming meeting amid stubborn inflation, hi...
Rising APRs are transforming solar financing, exposing homeowners to longer paybacks and higher total costs. This rep...
As AI workloads surge, choosing the right infrastructure partner matters. This guide compares CoreWeave and Nebius, w...
A rapid shift is redefining tech leadership along a coastal corridor from NYC to Miami. The next great american tech ...